ES2731729T3 - Uso de palmitoiletanolamida en combinación con opioides - Google Patents
Uso de palmitoiletanolamida en combinación con opioides Download PDFInfo
- Publication number
- ES2731729T3 ES2731729T3 ES15166284T ES15166284T ES2731729T3 ES 2731729 T3 ES2731729 T3 ES 2731729T3 ES 15166284 T ES15166284 T ES 15166284T ES 15166284 T ES15166284 T ES 15166284T ES 2731729 T3 ES2731729 T3 ES 2731729T3
- Authority
- ES
- Spain
- Prior art keywords
- palmitoylethanolamide
- opioid
- pea
- treatment
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20140876 | 2014-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2731729T3 true ES2731729T3 (es) | 2019-11-18 |
Family
ID=51179022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15166284T Active ES2731729T3 (es) | 2014-05-14 | 2015-05-04 | Uso de palmitoiletanolamida en combinación con opioides |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9801836B2 (https=) |
| EP (1) | EP2944309B1 (https=) |
| JP (1) | JP6563685B2 (https=) |
| KR (1) | KR102507891B1 (https=) |
| CN (1) | CN105079811B (https=) |
| AR (1) | AR100444A1 (https=) |
| AU (1) | AU2015202575B9 (https=) |
| BR (1) | BR102015011079A2 (https=) |
| CA (1) | CA2891049C (https=) |
| CY (1) | CY1121773T1 (https=) |
| DK (1) | DK2944309T3 (https=) |
| ES (1) | ES2731729T3 (https=) |
| HU (1) | HUE044915T2 (https=) |
| PL (1) | PL2944309T3 (https=) |
| PT (1) | PT2944309T (https=) |
| SM (1) | SMT201900345T1 (https=) |
| TR (1) | TR201908936T4 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2968345T3 (es) * | 2015-05-21 | 2024-05-09 | Scisparc Ltd | Combinaciones de oxicodona y palmitoiletanolamina de N-aciletanolamina para reducir los efectos secundarios asociados a los opioides |
| PH12018000077B1 (en) | 2017-07-05 | 2021-07-09 | Frimline Private Ltd | A pharmaceutical composition for neuropathic pain |
| PH12018000227A1 (en) | 2017-09-05 | 2019-03-11 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of chronic kidney disease |
| PH12021551384A1 (en) * | 2019-01-02 | 2022-03-28 | Celagenex Res India Pvt Ltd | Synergistic nutritional compositions for pain management |
| EP4681710A1 (en) * | 2024-07-18 | 2026-01-21 | EPITECH GROUP S.p.A. | 2-pentadecyl-2-oxazoline as an opioid adjuvant to prevent or treat hyperalgesia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1271266B (it) | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| ATE290858T1 (de) | 1999-08-06 | 2005-04-15 | Innovet Italia Srl | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin |
| JP2004536854A (ja) * | 2001-07-18 | 2004-12-09 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 頭髪及び／または頭皮のトリートメント組成物 |
| US20050245557A1 (en) * | 2003-10-15 | 2005-11-03 | Pain Therapeutics, Inc. | Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain |
| JP2012522004A (ja) * | 2009-03-27 | 2012-09-20 | アボット・ラボラトリーズ | カンナビノイド受容体リガンドである化合物 |
| ES2547133T5 (es) * | 2009-09-07 | 2019-02-15 | Epitech Group S P A | Composición que contiene palmitoiletanolamida ultramicronizada |
-
2015
- 2015-05-04 ES ES15166284T patent/ES2731729T3/es active Active
- 2015-05-04 PL PL15166284T patent/PL2944309T3/pl unknown
- 2015-05-04 DK DK15166284.8T patent/DK2944309T3/da active
- 2015-05-04 PT PT15166284T patent/PT2944309T/pt unknown
- 2015-05-04 TR TR2019/08936T patent/TR201908936T4/tr unknown
- 2015-05-04 SM SM20190345T patent/SMT201900345T1/it unknown
- 2015-05-04 EP EP15166284.8A patent/EP2944309B1/en active Active
- 2015-05-04 HU HUE15166284 patent/HUE044915T2/hu unknown
- 2015-05-12 CA CA2891049A patent/CA2891049C/en active Active
- 2015-05-13 AU AU2015202575A patent/AU2015202575B9/en active Active
- 2015-05-13 KR KR1020150066492A patent/KR102507891B1/ko active Active
- 2015-05-13 JP JP2015098334A patent/JP6563685B2/ja active Active
- 2015-05-13 US US14/711,112 patent/US9801836B2/en active Active
- 2015-05-13 CN CN201510243856.6A patent/CN105079811B/zh active Active
- 2015-05-14 AR ARP150101502A patent/AR100444A1/es unknown
- 2015-05-14 BR BR102015011079A patent/BR102015011079A2/pt not_active IP Right Cessation
-
2019
- 2019-05-29 CY CY20191100565T patent/CY1121773T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015221794A (ja) | 2015-12-10 |
| TR201908936T4 (tr) | 2019-07-22 |
| PL2944309T3 (pl) | 2019-09-30 |
| AU2015202575B2 (en) | 2020-03-05 |
| JP6563685B2 (ja) | 2019-08-21 |
| AU2015202575A1 (en) | 2015-12-03 |
| US9801836B2 (en) | 2017-10-31 |
| CA2891049A1 (en) | 2015-11-14 |
| AU2015202575B9 (en) | 2020-03-26 |
| CN105079811B (zh) | 2020-06-23 |
| HUE044915T2 (hu) | 2019-11-28 |
| CA2891049C (en) | 2023-02-21 |
| BR102015011079A2 (pt) | 2016-03-29 |
| AR100444A1 (es) | 2016-10-05 |
| US20150328173A1 (en) | 2015-11-19 |
| SMT201900345T1 (it) | 2019-07-11 |
| EP2944309B1 (en) | 2019-03-20 |
| PT2944309T (pt) | 2019-06-05 |
| CN105079811A (zh) | 2015-11-25 |
| KR20150130931A (ko) | 2015-11-24 |
| DK2944309T3 (da) | 2019-06-03 |
| KR102507891B1 (ko) | 2023-03-08 |
| CY1121773T1 (el) | 2020-07-31 |
| EP2944309A1 (en) | 2015-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2731729T3 (es) | Uso de palmitoiletanolamida en combinación con opioides | |
| CN105491885B (zh) | 疼痛药物组合及其用途 | |
| JP6216305B2 (ja) | 薬物過量摂取の治療のためのモルヒナン誘導体 | |
| JP2023076465A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| HUP0301822A2 (hu) | Gyógyszerkészítmény az akut, a krónikus fájdalom és/vagy a neuropátiás fájdalom és a migrének kezelésére | |
| BR112014000159A2 (pt) | composição oral, e, uso de uma composição oral | |
| ES2748274T3 (es) | Remedio para aliviar los problemas de la piel que comprende un derivado de morfinano o una sal de adición de ácido farmacológicamente aceptable del mismo como el principio activo | |
| JP2000508341A (ja) | 片頭痛の治療法及び薬効の強化組成物 | |
| CZ20012084A3 (cs) | Pouľití apomorfinu při výrobě léku pro léčbu organické erektilní dysfunkce u muľů | |
| EP1154795B1 (en) | Means for treating and diagnosing restless legs syndrome | |
| CN105828821A (zh) | 具有κ活性的阿片受体拮抗剂和沃替西汀用于治疗具有忧郁特征的抑郁障碍的用途 | |
| ES2980120T3 (es) | Formas de dosificación y usos terapéuticos de la L-4-cloroquinurenina | |
| JP2009539942A (ja) | ビフェプルノックス及びｌ−ｄｏｐａを含む組み合わせ製剤 | |
| JP2014505113A (ja) | 末梢作用性μオピオイドアンタゴニスト | |
| KR20250161056A (ko) | 플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제의 용도 | |
| MX2012005538A (es) | Combinacion de farmacos con teobromina y su uso en terapia. | |
| KR20090125748A (ko) | 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법 | |
| US20010034320A1 (en) | NK1-receptor antagonists for treating restless legs syndrome | |
| WO2016018178A1 (ru) | Комплексное антиникотиновое средство | |
| KR101971762B1 (ko) | 성기능장애의 치료에 사용하기 위한 a3 아데노신 수용체 리간드 | |
| TW202440096A (zh) | 雌激素受體降解劑之給藥方案 | |
| EP3590511A1 (en) | Therapeutic agent for alcohol use disorders | |
| ITMI20090174A1 (it) | Uso di memantina per il trattamento di disturbi dell umore | |
| MX2008002189A (en) | Synergistic pharmaceutical composition of ketorolac and lysine clonixinate | |
| WO2008075997A1 (en) | Method for treating opioid withdrawal syndrome |